CSIMarket
 


Enzon Pharmaceuticals inc   (ENZN)
Other Ticker:  
 

Cumulative Enzon Pharmaceuticals Inc 's Leverage Ratio for Trailing Twelve Months Period

ENZN's Leverage Ratio for Trailing Twelve Months Period and Total Liabilities, Equity growth


Select the Comparisons : Select the Ratio:

ENZN Leverage Ratio for Trailing Twelve Months Period

(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Equity Growth 2.88 % -8.74 % -17.47 % -24.05 % -30.01 %
Y / Y Total Liabilities Growth 0.03 % -0.04 % -49.76 % -49.77 % -48.25 %
Leverage Ratio for Trailing Twelve Months Period 14.9 15.02 14.72 17.51 19.44
Total Ranking # 2596 # 3925 # 4081 # 4189 # 4707
Seq. Equity Growth 39.36 % -7.71 % -11.32 % -9.8 % 23.62 %
Seq. Total Liabilities Growth -0.64 % 1.22 % 1.21 % -1.72 % -0.72 %


Leverage Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Dec 31 2023
On the trailing twelve months basis Due to debt repayement of -0.64% Enzon Pharmaceuticals Inc decreased Leverage Ratio for Trailing Twelve Months Period in the IV. Quarter to 14.9, above Enzon Pharmaceuticals Inc 's average Leverage Ratio for Trailing Twelve Months Period.
Leverage Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Biotechnology & Pharmaceuticals industry 56 other companies have achieved lower Leverage Ratio for Trailing Twelve Months Period than Enzon Pharmaceuticals Inc . While total ranking remained unchanged compare to previous quarter at no. .

What is Leverage Ratio?
Who are ENZN's Customers?
Leverage Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 57
Sector # 412
S&P 500 # 2543


Leverage Ratio for Trailing Twelve Months Period Statistics
High Average Low
15.02 3.1 0.02
(Sep 30 2023)   (Dec 31 2016)




Companies with similar average Leverage Ratio for Trailing Twelve Months Period for 12 months ending Dec 31 2023, within Biotechnology & Pharmaceuticals Industry Leverage Ratio for Trailing Twelve Months Period
Armata Pharmaceuticals Inc   24.77 
Enzon Pharmaceuticals inc   14.10 
Amgen Inc   13.38 
Halozyme Therapeutics Inc   11.52 
Cyclo Therapeutics Inc   5.51 
Atara Biotherapeutics Inc   5.16 
Axcella Health Inc   4.67 
Champions Oncology Inc   4.55 
Cidara Therapeutics Inc   4.53 
Aceragen Inc   4.22 
Biocardia Inc  4.22 
Inhibrx Inc   3.91 
Precision Biosciences Inc  3.68 
Protalix Biotherapeutics inc   3.45 
Windtree Therapeutics Inc  3.40 
Adaptimmune Therapeutics Plc  3.08 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com